By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Diagnostic testing in the clinical setting and providing services to biopharmaceutical companies88.5M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States88.5M100.00%